Literature DB >> 6230491

Characterization of new non-T, non-B acute lymphoblastic leukemia cell lines: analysis of surface antigens by quantitative cellular radioimmunoassay and flow cytometry.

J Okamura, H Okano, Y Ikuno, H Tasaka, S Motomura, M Letarte, E W Gelfand.   

Abstract

Two novel acute lymphoblastic leukemia (ALL) cell lines, HOON and HYON, have been established from patients with non-T, non-B ALL. The cell lines have been characterized and shown to express phenotypic markers on non-T, non-B ALL. By indirect immunofluorescence and flow cytometry they express Ia and common ALL (CALLA) antigens and are reactive with monoclonal antibodies BA-1, BA-2 and OKT-9. However, the cells do not express detectable amounts of B1 antigen or of cytoplasmic mu chain, which are markers of pre-B cells. Quantitation of Ia and CALLA antigens on HOON and HYON cell lines using a cellular radioimmunoassay revealed that both cells bind high levels of anti-Ia antibodies, 110 X 10(4) molecules per cell, and low levels of anti-CALLA antibodies, 7 X 10(4) molecules per cell. Although both HOON and HYON carry equivalent amounts of Ia on their surface, only the former is a good stimulator of the one-way mixed lymphocyte reaction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230491     DOI: 10.1016/0145-2126(84)90037-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Purification and characterization of the P-80 glycoprotein from human brain.

Authors:  N Girgrah; T F Cruz; M Letarte; M A Moscarello
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

2.  Identification of three antigens in human brain associated with similar antigens on human leukaemic cells.

Authors:  E J Quackenbush; T F Cruz; M A Moscarello; M Letarte
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

3.  Heterogeneous origin of established non-T,non-B cell lines from two adolescent patients with acute lymphoblastic leukemia.

Authors:  M Nagasaka-Yabe; S Maeda; O Mabuchi; H Misu; S Nakamura; Y Kobayashi; H Hirai; T Sugiyama
Journal:  Jpn J Cancer Res       Date:  1988-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.